INVESTINGTrading AbbVie as Its Drug Is Seen as Possible Coronavirus TreatmentBy Bret Kenwell20 hours ago
MARKETSStocks Post Worst Day of Year as Spreading Coronavirus Makes Wall Street JitteryBy Joseph Woelfel19 hours ago
MERGERS AND ACQUISITIONSAllergan Sells Drugs to Nestle and AstraZeneca Ahead of AbbVie Tie-UpBy M. Corey Goldman23 hours ago
MARKETSCoronavirus, Dow Futures Plunge, Google and Kobe Bryant - 5 Things You Must Know MondayBy Joseph WoelfelJan 27, 2020 6:18 AM EST
PRESS RELEASESAbbVie And Allergan Announce Agreements To Divest Brazikumab And ZenpepBy PR NewswireJan 27, 2020 1:15 AM EST
PRESS RELEASESSkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible ResultsBy PR NewswireJan 17, 2020 7:30 AM EST
PRESS RELEASESAllergan Teams Up With Super Bowl MVP Von Miller To Raise Awareness Of Glaucoma's Impact On Daily LivingBy PR NewswireJan 16, 2020 7:30 AM EST
PRESS RELEASESWarner Chilcott And Watson Resolve Antitrust Class Action Litigation With Direct And Indirect Purchasers Of Loestrin 24 Fe And Minastrin 24 FeBy PR NewswireJan 6, 2020 7:00 AM EST
INVESTINGAbbVie Selling Up to $28 Billion in Bonds to Acquire Allergan: ReportBy Scott Van VoorhisNov 12, 2019 10:00 AM EST
EARNINGSAllergan Tops Q3 Earnings, Bumps 2019 Sales Guidance Amid AbbVie TakeoverBy Martin BaccardaxNov 5, 2019 9:40 AM EST
MARKETSDow Futures, Uber, Shake Shack and China Trade - 5 Things You Must Know TuesdayBy Joseph WoelfelNov 5, 2019 6:17 AM EST
INVESTINGAbbVie Posts Stronger-Than-Expected Earnings, Lifts ForecastBy M. Corey GoldmanNov 1, 2019 9:35 AM EDT
STOCKSEndo, Opioid Producers Said to Mull Unusual Lawsuit Settlement; Shares RiseBy Rob DanielOct 1, 2019 10:33 AM EDT
MARKETSBroadcom, WeWork, Dow Futures, China Trade, Cloudflare - 5 Things You Must KnowBy Joseph WoelfelSep 13, 2019 6:37 AM EDT
STOCKSMallinckrodt Plunges on Report It's Considering Filing for BankruptcyBy M. Corey GoldmanSep 5, 2019 9:33 AM EDT
INVESTINGAllergan Reaches Settlement With Ohio Plaintiffs in Federal Opioid LitigationBy M. Corey GoldmanAug 30, 2019 9:39 AM EDT
INVESTINGEndo Surges as Opioid Maker Reaches Settlement in Landmark LawsuitBy Scott Van VoorhisAug 20, 2019 10:43 AM EDT
INVESTINGEndo, Allergan Said Nearing Deals to Limit Ohio Litigation Over OpioidsBy Simon ConstableAug 20, 2019 7:23 AM EDT
MARKETSDow Finished Up 300 Points, Rebound From Worst Day of the YearBy Rob LenihanAug 6, 2019 4:37 PM EDT
